Arrowhead Pharmaceuticals, Inc. (ARWR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 1.84B | 1.17B | 950.64M | 946.92M | 1.14B | 570.54M | 695.47M | 450.06M | 541.65M | 237.9M | 419.52M | 470.17M |
| Cash & Short-Term Investments | 1.78B | 916.61M | 919.37M | 900.37M | 1.1B | 552.93M | 680.96M | 436.67M | 523.11M | 220.28M | 403.63M | 451.7M |
| Cash Only | 188.52M | 201.64M | 226.55M | 129.79M | 185.71M | 53.89M | 102.69M | 69.4M | 127.7M | 58.22M | 110.89M | 105.33M |
| Short-Term Investments | 1.6B | 714.97M | 692.82M | 770.58M | 911.7M | 499.05M | 578.28M | 367.27M | 395.41M | 162.06M | 292.74M | 346.37M |
| Accounts Receivable | 15.69M | 218.87M | 6.82M | 9.7M | 2.37M | 2.5M | 0 | 0 | 0 | 0 | 0 | 1.25M |
| Days Sales Outstanding | 143.14 | 39.32 | 2.96 | 19.77 | 0.4 | 92 | - | - | - | - | - | 203.22 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.05M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | 279.34 |
| Other Current Assets | 18.25M | 38.91M | 13.52M | 13.16M | 11.68M | 5.74M | 4.97M | 4.18M | 7.51M | 7.1M | 7.08M | 7.16M |
| Total Non-Current Assets | 428.51M | 429.79M | 434.66M | 433.69M | 438.28M | 443.16M | 444.33M | 433.7M | 413.5M | 388.39M | 346.03M | 325.69M |
| Property, Plant & Equipment | 417.62M | 421.94M | 426.41M | 425.05M | 429.25M | 431.94M | 431.29M | 420.25M | 403.88M | 378.32M | 335.56M | 272.04M |
| Fixed Asset Turnover | 0.18x | 0.62x | 0.60x | 0.07x | 1.26x | 0.01x | - | - | - | 0.01x | 0.05x | 0.06x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 6.01M | 6.44M | 6.86M | 7.29M | 7.71M | 8.14M | 8.56M | 8.99M | 9.41M | 9.84M | 10.26M | 10.69M |
| Long-Term Investments | 4.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42.76M |
| Other Non-Current Assets | 187K | 1.41M | 1.39M | 1.35M | 1.31M | 3.08M | 4.48M | 4.46M | 210K | 232K | 210K | 210K |
| Total Assets | 2.27B | 1.6B | 1.39B | 1.38B | 1.57B | 1.01B | 1.14B | 883.76M | 955.15M | 626.29M | 765.55M | 795.86M |
| Asset Turnover | 0.04x | 0.18x | 0.19x | 0.02x | 0.42x | 0.00x | - | - | - | 0.01x | 0.02x | 0.02x |
| Asset Growth % | 44.15% | 58.25% | 21.54% | 56.22% | 64.74% | 61.86% | 48.89% | 11.05% | 7.16% | -29.75% | 10.64% | 5.86% |
| Total Current Liabilities | 295.22M | 347.43M | 195.49M | 194.53M | 220.54M | 93.76M | 103.17M | 96.71M | 65.17M | 63.72M | 105.46M | 70.23M |
| Accounts Payable | 30.75M | 32.94M | 17.67M | 33.05M | 9.98M | 14.46M | 11.39M | 26.55M | 8.52M | 4.46M | 35.87M | 7.87M |
| Days Payables Outstanding | 450.03 | - | - | - | - | - | 347.29 | 333.7 | 130.53 | 435.14 | 521.39 | 242.16 |
| Short-Term Debt | 47.77M | 40M | 40M | 47.01M | 71.78M | 8.19M | 6.34M | 6.05M | 5.29M | 3.42M | 10.56M | 2.82M |
| Deferred Revenue (Current) | 108.54M | 111.93M | 2.4M | 22.98M | 43.27M | 0 | 0 | 0 | 0 | 0 | 866K | 16.91M |
| Other Current Liabilities | 87.79M | 10.68M | 10.81M | 72.19M | 78.9M | 59.84M | 63.45M | 48.32M | 37.63M | 47.06M | 40.2M | 38.19M |
| Current Ratio | 6.23x | 3.38x | 4.86x | 4.87x | 5.15x | 6.09x | 6.74x | 4.65x | 8.31x | 3.73x | 3.98x | 6.69x |
| Quick Ratio | 6.23x | 3.38x | 4.86x | 4.87x | 5.15x | 6.09x | 6.74x | 4.65x | 8.31x | 3.73x | 3.98x | 6.55x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | 240.4 |
| Total Non-Current Liabilities | 1.37B | 694.06M | 686.39M | 666.28M | 668.73M | 863.86M | 845.57M | 448.07M | 394.57M | 388.85M | 372.93M | 343.64M |
| Long-Term Debt | 1.23B | 163.11M | 214.88M | 560.59M | 561.2M | 754.57M | 734.54M | 336.03M | 280.94M | 273.69M | 268.33M | 0 |
| Capital Lease Obligations | 100.11M | 102.13M | 104.11M | 105.69M | 107.53M | 109.3M | 111.03M | 112.04M | 113.63M | 115.16M | 104.61M | 79.91M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 375M | 367.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 263.73M |
| Total Liabilities | 1.67B | 1.04B | 881.88M | 860.81M | 889.27M | 957.62M | 948.74M | 544.78M | 459.75M | 452.57M | 478.39M | 413.87M |
| Total Debt | 1.37B | 312.77M | 366.28M | 713.29M | 740.51M | 872.05M | 851.91M | 454.12M | 399.86M | 392.27M | 383.5M | 82.73M |
| Net Debt | 1.18B | 111.12M | 139.74M | 583.49M | 554.8M | 818.16M | 749.23M | 384.73M | 272.15M | 334.06M | 272.61M | -22.6M |
| Debt / Equity | 2.29x | 0.56x | 0.73x | 1.37x | 1.08x | 15.55x | 4.46x | 1.34x | 0.81x | 2.26x | 1.34x | 0.22x |
| Debt / EBITDA | - | 6.63x | 7.25x | - | 1.91x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | 2.35x | 2.77x | - | 1.43x | - | - | - | - | - | - | - |
| Interest Coverage | -5.92x | 2.26x | 2.67x | -6.35x | 18.08x | -7.09x | -10.80x | -33.15x | -16.53x | -24.84x | -19.71x | -19.04x |
| Total Equity | 598.92M | 562.7M | 503.42M | 519.81M | 684.23M | 56.08M | 191.06M | 338.97M | 495.4M | 173.71M | 287.16M | 381.99M |
| Equity Growth % | -12.47% | 903.47% | 163.48% | 53.35% | 38.11% | -67.72% | -33.47% | -11.26% | 6.51% | -56.17% | -31.36% | -19.44% |
| Book Value per Share | 4.21 | 4.00 | 3.71 | 3.74 | 5.09 | 0.45 | 1.57 | 2.73 | 4.02 | 1.62 | 2.68 | 3.57 |
| Total Shareholders' Equity | 613.98M | 568.42M | 466.05M | 522.31M | 683.32M | 52.59M | 185.44M | 330.55M | 483.79M | 160.41M | 271.34M | 364.83M |
| Common Stock | 236K | 233K | 231K | 230K | 230K | 218K | 217K | 217K | 217K | 200K | 200K | 199K |
| Retained Earnings | -1.73B | -1.6B | -1.63B | -1.6B | -1.43B | -1.8B | -1.63B | -1.45B | -1.28B | -1.16B | -1.03B | -916.35M |
| Treasury Stock | -53.19M | -53.19M | -53.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 742K | 6.7M | 6.44M | 5.36M | 4.39M | 4.14M | 4.75M | -987K | -1.09M | -1.25M | -3.22M | -411K |
| Minority Interest | -15.06M | -5.72M | 37.36M | -2.51M | 904K | 3.49M | 5.62M | 8.43M | 11.61M | 13.31M | 15.82M | 17.16M |